STOCK TITAN

Rani Therapeutics Holdings, Inc. (RANI) details director option holding

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Michelle Gilson, a director of Rani Therapeutics Holdings, Inc., reports beneficial ownership of a stock option covering 12,500 shares of Class A Common Stock. The option has an exercise price of $7.46 per share, expires on October 30, 2026, is fully vested and exercisable, and is held directly.

Positive

  • None.

Negative

  • None.
Insider Gilson Michelle
Role Director
Type Security Shares Price Value
holding Stock Option (right to buy) F1 -- -- --
Holdings After Transaction: Stock Option (right to buy) — 12,500 shares (Direct)
Footnotes (1)
  1. F1. The shares subject to the option are fully vested and exercisable.
Underlying shares 12,500 shares Stock Option (right to buy) for Class A Common Stock
Exercise price $7.46 per share Exercise price of reported stock option
Option expiration date 2026-10-30 Expiration date of the stock option
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) for 12,500 shares"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock underlying the option"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
beneficial ownership financial
"initial statement of beneficial ownership of securities by a director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
fully vested and exercisable financial
"footnote: The shares subject to the option are fully vested and exercisable"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider position did Michelle Gilson report for RANI on this Form 3?

Michelle Gilson reported a stock option covering 12,500 shares of Rani Therapeutics’ Class A Common Stock, held directly as part of her beneficial ownership as a director.

What is the exercise price of Michelle Gilson’s RANI stock option?

The reported stock option has an exercise price of $7.46 per share. This price is the cost per share to convert the option into Class A Common Stock before expiration.

When does Michelle Gilson’s reported RANI stock option expire?

The stock option reported by Michelle Gilson expires on October 30, 2026. She may exercise the option any time before this expiration date, subject to applicable plan and company rules.

Are Michelle Gilson’s RANI stock options vested according to this Form 3?

Yes. A footnote states the shares subject to the option are fully vested and exercisable, meaning they are currently available to be exercised into Class A Common Stock.

Is Michelle Gilson’s ownership of the RANI option direct or indirect?

The Form 3 classifies the ownership as direct. This indicates the stock option is held in her own name rather than through a trust, fund, or other indirect entity.

Does this RANI Form 3 show any stock purchases or sales by Michelle Gilson?

No. The report lists a holding entry for a stock option only, with no recorded buy or sell transactions and no change in share ownership indicated.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Gilson Michelle

(Last)(First)(Middle)
C/O RANI THERAPEUTICS LLC
2051 RINGWOOD AVE.

(Street)
SAN JOSE CALIFORNIA 95131

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2026
3. Issuer Name and Ticker or Trading Symbol
Rani Therapeutics Holdings, Inc. [ RANI ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (1)10/30/2026Class A Common Stock12,500$7.46D
Explanation of Responses:
1. The shares subject to the option are fully vested and exercisable.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Carlos Perez, Attorney-in-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)